Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

47results about How to "Suitable for implantation" patented technology

Layered drug delivery polymer monofilament fibers

The present invention is directed generally to a layered polymeric monofilament fiber drug delivery device, where each layer of the device can contain a different polymer, drug, additive, or any combination or mixture thereof. The layered nature of the current monofilament polymeric monofilament device provides the capability to modulate the release of one or more drugs and / or the mechanical properties of the fiber so that drug release and device failure can be separately tuned to provide for the tailored introduction of therapeutically effective drugs or agents to a target tissue. Moreover, the fiber may comprise more than one distinct segments along its length, each segment itself having different combinations and / or numbers of layers thereby providing even greater freedom in the design of the therapeutic delivery device. The invention is also directed to a method of manufacturing such a layered polymeric monofilament fiber drug delivery device, and methods of treatment using such devices.
Owner:CALIFORNIA INST OF TECH

Compounds and methods for modulating cell adhesion

Cyclic peptides comprising a cadherin cell adhesion recognition sequence HAV, and compositions comprising such cyclic peptides, are provided. Methods for using such peptides for modulating cadherin-mediated cell adhesion in a variety of contexts are also provided.
Owner:ADHEREX TECH

Cardiovascular power source for automatic implantable cardioverter defibrillators

InactiveUS20100160994A1Increased power demandSuitable for implantationPiezoelectric/electrostriction/magnetostriction machinesTransvascular endocardial electrodesPower storageAutomatic Implantable Cardioverter-Defibrillators
Aspects according to the present invention provide a method and implant suitable for implantation inside a human body that includes a power consuming means responsive to a physiological requirement of the human body, a power source and a power storage device. The power source comprises a sheathed piezoelectric assembly that is configured to generate an electrical current when flexed by the tissue of the body and communicate the generated current to the power storage device, which is electrically coupled to the power source and to the power consuming means.
Owner:BOARD OF RGT THE UNIV OF TEXAS SYST

Health Monitoring System

ActiveUS20150196225A1Effective monitoring and follow upEffective follow-upSurgeryVaccination/ovulation diagnosticsPeripheralElectromagnetic field
The present invention relates to a health monitoring system comprising an implantable sensor configured to measure impedance within a body tissue of the subject resulting from an electrical current flowing through said body tissue, wherein the body tissue is sub-dermal or subcutaneous tissue of said subject, the sensor including a powering and communication circuit having a coil configured to be powered by an electromagnetic field and to communicate with external devices. Further, the system comprises a reader module including a coil configured to produce the electromagnetic field for powering the powering and communication circuit and for communicating with the powering and communication circuit, a computing device comprising a display device, a processing device and at least one storage device, the computing device being configured to communicate with other devices via at least one wireless network and a monitoring engine for determining or monitoring at least one physiological parameter based on measured impedance, wherein the reader module and the computing device and the monitoring engine are configured to communicate with each other.
Owner:D T R DERMAL THERAPY RES

Double baffle vascular occluder

A vascular occluder includes first and second baffle members which are formed of an expansion device such as a stent across which extends an impermeable membrane. The baffle members are held at a given separation by spacer elements. The separation creates a chamber between the baffle members in which the blood is able to stagnate, thereby creating a second occlusion barrier. One of the baffle members may have an aperture within its membrane for receiving a delivery catheter for delivery of thrombogenic agent into the chamber. The occluder has a given length, thereby making it suitable for implantation in difficult vessel sections and is also able to avoid problems of recanalization of the vessel which can occur with prior art occluders.
Owner:COOK MEDICAL TECH LLC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products